ABBOTT PARK, Ill. – Oct. 30, 2024 – Abbott today announced that its FreeStyle Libre 2 and 3 systems can now be worn during common imaging procedures, such as X-rays, CT scans and MRIs*. The U.S. Food and Drug Administration (FDA) cleared the removal of the imaging contraindication, making Abbott’s systems the first and only patient-applied continuous glucose monitoring (CGM) sensors approved for these screenings..

伊利诺伊州雅培公园——2024年10月30日——雅培今天宣布，其FreeStyle Libre 2和3系统现在可以在常规成像程序中佩戴，如X射线、CT扫描和MRI*。美国食品和药物管理局（FDA）清除了成像禁忌症，使雅培系统成为第一个也是唯一一个被批准用于这些筛查的患者应用连续血糖监测（CGM）传感器。。

People who use FreeStyle Libre 2 and 3 systems rely on their CGM sensors to make important decisions about their diabetes, including when to take insulin. They will no longer have to remove and discard their CGM sensor before its wear time has ended, providing them with increased convenience and the potential to save money. .

使用FreeStyle Libre 2和3系统的人依靠他们的CGM传感器来做出关于糖尿病的重要决定，包括何时服用胰岛素。在CGM传感器的磨损时间结束之前，他们不再需要拆除和丢弃CGM传感器，这为他们提供了更多的便利和节省资金的潜力。。

'For people with diabetes, especially those using insulin, removing a CGM sensor for long periods can be problematic,' said Carol Wysham, M.D., clinical professor of medicine at the University of Washington School of Medicine and section head of the department of diabetes and endocrinology at Rockwood Clinic in Spokane.

华盛顿大学医学院临床医学教授、斯波坎洛克伍德诊所糖尿病与内分泌学系主任卡罗尔·怀沙姆（CarolWysham）医学博士说：“对于糖尿病患者，尤其是使用胰岛素的患者，长时间移除CGM传感器可能会产生问题。”。

'Previously, patients had to remove their sensors during these procedures, resulting in several hours without critical data, especially if they didn’t have a replacement sensor. The removal of the imaging contraindication from Abbott’s FreeStyle Libre 2 and 3 systems is a big win for patients, allowing them to keep their sensors on and avoid lost data.'.

“以前，患者必须在这些过程中移除传感器，导致几个小时没有关键数据，特别是如果他们没有更换传感器的话。从雅培的FreeStyle Libre 2和3系统中删除成像禁忌症对患者来说是一个巨大的胜利，使他们能够保持传感器工作并避免数据丢失。”。

Diabetes can cause complications like cardiovascular disease, neuropathy, and infections3. Imaging procedures are often part of diabetes care: X-rays detect bone injuries, CT scans identify kidney stones and blood clots, and MRIs provide detailed images of organs and tissues to identify issues such as brain injuries, ischemic heart disease and fatty liver disease4,5..

糖尿病可引起心血管疾病，神经病和感染等并发症3。成像程序通常是糖尿病护理的一部分：X射线检测骨损伤，CT扫描识别肾结石和血栓，MRI提供器官和组织的详细图像，以识别诸如脑损伤，缺血性心脏病和脂肪肝疾病等问题4,5。。

Abbott rigorously tested its FreeStyle Libre 2 and 3 systems sensors to ensure they remain effective after radiologic procedures*. This testing led the FDA to clear the removal of the contraindication requirement, with no changes made to the sensor.

雅培严格测试了其FreeStyle Libre 2和3系统传感器，以确保它们在放射学程序后保持有效*。。

'Continuous glucose monitoring is essential for diabetes management,' said Anila Bindal, M.D., associate medical director for Abbott's diabetes care business. 'We’ve seen first-hand how consistent use of Libre technology benefits people living with diabetes. This contraindication removal aligns with Abbott’s commitment to provide easy, convenient, and affordable technology for diabetes management.'.

雅培糖尿病护理业务的副医疗总监、医学博士阿尼拉·宾达尔（AnilaBindal）说，持续血糖监测对糖尿病管理至关重要我们亲眼目睹了Libre技术的持续使用对糖尿病患者的益处。这种禁忌症的消除符合雅培为糖尿病管理提供简单，方便和负担得起的技术的承诺。”。

About Abbott:

关于雅培：

Abbott is a global healthcare leader that helps people live more fully at all stages of life. Our portfolio of life-changing technologies spans the spectrum of healthcare, with leading businesses and products in diagnostics, medical devices, nutritionals and branded generic medicines. Our 114,000 colleagues serve people in more than 160 countries.

雅培（Abbott）是一家全球医疗保健领导者，致力于帮助人们在生命的各个阶段都生活得更加充实。我们的生命改变技术组合涵盖了医疗保健领域，拥有诊断、医疗器械、营养品和品牌仿制药领域的领先业务和产品。我们的114000名同事为160多个国家的人民服务。